Neuroclast was established to provide clinicians with access to technology that enables opportunities of transformative potential and positive clinical outcomes for patients with brain cancer, neurodegenerative disease and psychiatric disorders. 

Our strategic version is centred upon three over-arching tenets: to help preserve life with onco-functional insight, to investigate brain stimulation therapies to ameliorate suffering, and contribute to the new era of localisation of neural function.

With a focus on neuro-oncology surgery, Neuroclast is also a novel medical device distributor and clinical research partner dedicated to data collection and analysis with regards to clinical outcomes, functional mapping of the human brain, and optimisation of treatment paradigms with state of the art medical technologies. 

We are a collective of neuroscientists, researchers, application specialists and academics that are 'building for the decade' by investing in the products developed by our distribution partners to enable clinicians to experience new technologies for themselves - applied by experts motivated by positive clinical outcomes. We are 'in pursuit', in that our goals are driven by advances in medical technology and clinical research, which is constantly evolving.

Our distribution partners:
Nexstim OYJ (Finland)
inomed Medizintechnik GmbH (Germany)
WISE srl (Italy)
Fundamental Surgery (London)
g.tec (Austria)

Neuroclast

Org chart

Teams

Offices